These findings were also validated in another BRCA2-mutated ovarian cancer cell line Kuramochi (Supplementary Fig. 2A, B), indicating that Polθ plays a central role in ALDH1A1-mediated olaparib resistance. The gene discussed is BRCA2; the disease is ovarian cancer.